Ownership and insider activity for Chemed Corporation (CHE): recent transactions by executives and directors. Track how corporate insiders are trading the stock.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Price
| Price | $534.72 (closing price, October 30, 2026) |
| Market Cap | $7.0B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-20 | Wherley Joel L | A-Award | 12,686 | $6.5M |
| 2026-10-20 | LEE SPENCER S | A-Award | 7,125 | $3.7M |
| 2026-10-20 | Judkins Brian C | A-Award | 9,392 | $4.8M |
| 2026-10-20 | HUTTON THOMAS C | A-Award | 3,964 | $2.0M |
| 2026-10-20 | Witzeman Michael D | A-Award | 12,686 | $6.5M |
| 2026-10-20 | MCNAMARA KEVIN J | A-Award | 36,693 | $18.8M |
| 2026-09-30 | LEE SPENCER S | M-Exempt | 12,099 | $5.4M |
| 2026-09-30 | LEE SPENCER S | M-Exempt | 12,099 | $5.4M |
| 2026-09-30 | LEE SPENCER S | F-InKind | 11,160 | $5.7M |
| 2026-09-28 | MCNAMARA KEVIN J | S-Sale | 2,000 | $1.0M |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15.3M | $11.1M | $4.8M | $6.2M | $162.7M | $32.9M | $74.1M | $264.0M | $178.3M | $74.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $132.0M | $113.7M | $119.5M | $143.8M | $126.9M | $137.2M | $139.4M | $181.5M | $171.2M | $182.6M |
| Inventory | $5.8M | $5.3M | $5.7M | $7.5M | $7.1M | $10.1M | $10.3M | $12.0M | $8.2M | $7.5M |
| Total Current Assets | $169.9M | $176.0M | $159.8M | $190.7M | $329.4M | $230.3M | $272.6M | $500.8M | $394.7M | $302.6M |
| Property, Plant & Equipment | $121.3M | $143.0M | $162.0M | $287.4M | $311.3M | $318.7M | $335.4M | $330.2M | $328.2M | $336.8M |
| Goodwill | $472.4M | $476.9M | $510.6M | $577.4M | $578.6M | $578.6M | $581.3M | $585.0M | $666.7M | $667.0M |
| Intangible Assets | $55.1M | $54.9M | $68.3M | $126.4M | $118.1M | $108.1M | $99.7M | $90.3M | $92.2M | $82.8M |
| Total Assets | $880.1M | $920.0M | $975.5M | $1.27B | $1.43B | $1.34B | $1.44B | $1.67B | $1.67B | $1.64B |
| Accounts Payable | $39.6M | $48.4M | $50.1M | $51.1M | $54.2M | $73.0M | $41.9M | $64.0M | $44.1M | $53.5M |
| Short-term Debt | $8.8M | $10.0M | 0 | 0 | 0 | 0 | $5.0M | $15.7M | 0 | $51.9M |
| Total Current Liabilities | $171.8M | $193.5M | $191.7M | $262.2M | $299.1M | $302.4M | $297.2M | $312.1M | $285.7M | $287.1M |
| Long-term Debt | $100.0M | $91.2M | $89.2M | $90.0M | 0 | $185.0M | $92.5M | 0 | 0 | 0 |
| Total Liabilities | $356.0M | $379.7M | $384.2M | $541.7M | $533.7M | $719.5M | $643.3M | $560.2M | $549.6M | $660.6M |
| Retained Earnings | $958.1M | $1.04B | $1.23B | $1.43B | $1.72B | $1.97B | $2.20B | $2.45B | $2.72B | $2.96B |
| Total Equity | $524.1M | $540.4M | $591.3M | $726.6M | $901.2M | $623.3M | $798.7M | $1.11B | $1.12B | $979.4M |
| Total Debt | $108.8M | $101.2M | $89.2M | $215.9M | $135.4M | $323.5M | $247.0M | $155.1M | $140.8M | $154.8M |
| Net Debt | $93.4M | $90.1M | $84.4M | $209.8M | -$27.3M | $290.6M | $172.9M | -$108.8M | -$37.5M | $80.2M |
| Working Capital | -$1.9M | -$17.5M | -$31.8M | -$71.5M | $30.3M | -$72.1M | -$24.6M | $188.8M | $109.1M | $15.5M |
Financial Health
| Debt / Equity | 0.46 |
| Current Ratio | 1.11 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 10.35 |
Profitability
| Return on Equity | 32.10% |
| Return on Invested Capital | 19.17% |
| Return on Assets | 16.43% |
| Gross Margin | 31.65% |
| Operating Margin | 13.94% |
| Net Margin | 10.61% |
Related companies: OPCH · ADUS · AVAH · HCA · 0J1R.L · 0RPS.L · THC · EHC
Explore sector: Healthcare · Medical - Care Facilities
More sections of CHE: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks